HARMONY BIOSCIENCES HOLDINGS, INC. Income Taxes Paid
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Income Taxes Paid of $21.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for the quarter ending 2025-12-31 was -$15.61M, a 174.03% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $59.00K, a 99.64% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for the quarter ending 2024-12-31 was $21.09M, a 80.38% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for the quarter ending 2024-09-30 was $16.46M, a 1.18% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for fiscal 2025 was $19.82M, a 75.11% decline from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for fiscal 2024 was $79.64M, a 65.10% increase from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for fiscal 2023 was $48.23M, a 281.44% increase from fiscal 2022.
- HARMONY BIOSCIENCES HOLDINGS, INC. income taxes paid, net for fiscal 2022 was $12.64M, a 339.83% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.06M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | -$15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$15.55M derived: sum of 2 quarters · filed 2026-02-24 | $19.82M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $35.43M 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $35.37M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $21.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $37.54M derived: sum of 2 quarters · filed 2026-02-24 | $79.64M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $16.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $58.55M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $42.09M 10-Q · filed 2025-08-05 | |||
| 2023-12-31 | $11.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $28.34M derived: sum of 2 quarters · filed 2026-02-24 | $48.23M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $16.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $36.54M 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $19.89M 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $12.36M derived: sum of 2 quarters · filed 2025-02-25 | $12.64M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $9.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $9.70M 10-Q · filed 2023-10-31 | ||
| 2022-06-30 | $290.00K 10-Q · filed 2023-08-01 | |||
| 2021-12-31 | $2.88M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |